Nevertheless, another group has reported that IFN‐γ can downregulate the antitumor immune response by promoting regulatory T‐cell (Treg) function and suppressing effector T‐cell function via enhancement of indoleamine 2,3‐dioxygenase secretion from cancer cells and antigen‐presenting cells.19 The gene discussed is IDO2; the disease is cancer.